Skip to main content

Table 1 Expression of IGF2BP2 according to clinicopathological features of 60 pancreatic cancer patients

From: Up-regulation of IGF2BP2 by multiple mechanisms in pancreatic cancer promotes cancer proliferation by activating the PI3K/Akt signaling pathway

Characteristic

High

Low

P-value

Age

31

29

0.586

 ≥ 65 years

16

17

 

 < 65 years

15

12

 

Sex

32

28

0.63

 Male

21

20

 

 Female

11

8

 

Grade

  

0.034*

 Good

2

3

 

 Moderate

19

10

 

 Poor

23

3

 

TNM

  

0.02*

 I&II

22

12

 

 III&IV

9

17

 

Size

  

< 0.001*

 ≥ 2.5 cm

20

8

 

 < 2.5 cm

9

23

 

CA199

  

0.342

 ≥ 100

33

10

 

 < 100

11

6

 
  1. *Statistical significant difference